Pacira Pharmaceuticals Inc-DE

21. Aug. 2026, 19:56 UTC

Pacira Biosciences Inc. shares are higher during Friday's session, recovering from a midday dip amid positive sentiment in the broader market.

20. Aug. 2026, 20:06 UTC

Pacira Biosciences Inc shares are lower today, continuing a decline from Wednesday's close. The stock remains below its 20-day moving average.

19. Aug. 2026, 19:46 UTC

Pacira Biosciences Inc. shares are higher today, reflecting a broader market trend amid declining bond yields. The stock remains below its 20-day moving average.

18. Aug. 2026, 20:03 UTC

Shares of Pacira Biosciences are higher, reflecting broader market strength. The stock remains below its 20-day moving average and near the lower end of its trading range.

17. Aug. 2026, 19:26 UTC

Pacira Biosciences Inc shares are higher following Truist Securities' reinstatement of coverage with a Buy rating and a price target of $30.00.

14. Aug. 2026, 19:36 UTC

Pacira Biosciences Inc shares are lower, marking the seventh consecutive decline. Broader market sentiment is affected by a reported drop in retail sales for July.

13. Aug. 2026, 20:06 UTC

Pacira Biosciences Inc shares fell during Thursday's session, continuing a trend of declines and remaining below the 20-day moving average. No specific news was identified.

12. Aug. 2026, 20:01 UTC

Pacira Biosciences Inc's shares are lower today, continuing a downward trend with a cumulative return of -3.36% since Tuesday. No specific news was identified.

11. Aug. 2026, 19:16 UTC

Shares of Pacira Biosciences Inc. are lower today, continuing a trend of three consecutive declines. The stock is trading below its 20-day moving average.

10. Aug. 2026, 19:36 UTC

Pacira Biosciences Inc is trading lower, continuing a decline since Friday. The stock remains below its 20-day moving average amid broader market volatility.

7. Aug. 2026, 20:02 UTC

Pacira Biosciences shares are lower despite positive two-year Phase 1 trial results for PCRX-201, an investigational gene therapy for knee osteoarthritis.

6. Aug. 2026, 19:52 UTC

Pacira Biosciences Inc. shares are higher following positive two-year results from its Phase 1 trial for PCRX-201, a gene therapy for knee osteoarthritis.

5. Aug. 2026, 20:03 UTC

Pacira Biosciences reported improved earnings but lowered its 2026 revenue guidance, contributing to a decline in shares since Tuesday's close.

4. Aug. 2026, 19:53 UTC

Pacira Biosciences Inc is higher today, supported by overall market strength and a decline in crude oil prices easing inflation concerns.

3. Aug. 2026, 20:06 UTC

Pacira Biosciences Inc. shares are higher today, reflecting broader market gains led by major stocks, despite no specific company news identified.

31. Juli 2026, 20:02 UTC

Pacira Biosciences Inc's shares are lower today, reaching a session low earlier. The price remains above its 20-day moving average despite the decline.

30. Juli 2026, 17:16 UTC

Pacira Biosciences is advancing during Thursday's session, regaining momentum after earlier pulling back from a session high amid broader market optimism.

29. Juli 2026, 20:04 UTC

Shares of Pacira Biosciences Inc. are lower today, continuing a decline since Tuesday's close. The stock reached an early high before falling significantly.

28. Juli 2026, 19:56 UTC

Shares of Pacira Biosciences Inc. are higher, driven by survey findings on orthopedic pain's impact on the workforce and strong interest in non-opioid treatments.

27. Juli 2026, 18:51 UTC

Pacira Biosciences advances PCRX-201 to commercial manufacturing, allowing patient enrollment in Phase 2 ASCEND study. Shares are higher as investor confidence strengthens.

24. Juli 2026, 17:16 UTC

Pacira Biosciences Inc shares are lower today, with no specific news driving the decline. Broader market sentiment is impacted by falling crude oil prices.

22. Juli 2026, 18:06 UTC

Pacira Biosciences Inc shares are lower in Wednesday's session, pulling back from earlier gains amid broader market caution and rising crude oil prices.

21. Juli 2026, 19:56 UTC

Pacira Biosciences Inc is trading higher, reflecting broader market interest in technology and AI sectors ahead of upcoming earnings reports.

20. Juli 2026, 19:46 UTC

Pacira Biosciences Inc shares are trading lower today, having retraced from an earlier high. No specific news was identified to explain the decline.